Stock Research: ICU Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

ICU Medical

NasdaqGS:ICUI US44930G1076
45
  • Value
    47
  • Growth
    34
  • Safety
    Safety
    74
  • Combined
    55
  • Sentiment
    48
  • 360° View
    360° View
    45
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ICU Medical, Inc. develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care. The company operates in the medical devices industry and offers products such as IV pumps, connectors, and catheters. In the last fiscal year, the company had a market cap of $3,140 million, profits of $825 million, and revenue of $2,382 million with 15000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 45 (better than 45% compared with alternatives), overall professional sentiment and financial characteristics for the stock ICU Medical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for ICU Medical. Only the consolidated Value Rank has an attractive rank of 74, which means that the share price of ICU Medical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 74% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 34, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 47, meaning the company has a riskier financing structure than 53% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 52% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 48. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 53 82 59
Growth
34 19 3 23
Safety
Safety
47 69 54 100
Sentiment
48 36 31 25
360° View
360° View
45 36 30 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 60 22 58
Opinions Change
50 50 50 50
Pro Holdings
n/a 63 44 19
Market Pulse
57 26 43 44
Sentiment
48 36 31 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 53 82 59
Growth
34 19 3 23
Safety Safety
47 69 54 100
Combined
55 38 35 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
71 44 69 56
Price vs. Earnings (P/E)
73 56 83 64
Price vs. Book (P/B)
77 73 85 68
Dividend Yield
1 1 1 1
Value
74 53 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
4 10 8 10
Profit Growth
65 13 19 40
Capital Growth
58 22 47 45
Stock Returns
26 85 23 63
Growth
34 19 3 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
29 40 22 87
Refinancing
66 49 71 59
Liquidity
42 59 55 94
Safety Safety
47 69 54 100

Similar Stocks

Discover high‑ranked alternatives to ICU Medical and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

HF Sinclair

NYSE:HFC
Country: USA
Industry: Oil & Gas Refining
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.